ALLENA PHARMACEUTICALS BOSTON
Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to create innovative treatments for patients with rare and severe metabolic and kidney disorders. One of their notable achievements includes the positive topline results from the URIROX-1 Trial and from Study 206, which are significant contributions to the medical field.
ALLENA PHARMACEUTICALS BOSTON
Social Links:
Industry:
Biotechnology
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.allenapharma.com
Status:
Active
Similar Organizations
Adicet Bio
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Adnovate Clinical
Adnovate Clinical is a biotechnology industry.
AlphaThera
AlphaThera is a biotechnology industry.
Functional Biosciences
Functional Biosciences is a biotechnology industry firm.
Landmark Bio
Landmark Bio is a biotechnology industry.
RAGE Biotech
RAGE Biotech is a biotechnology industry.
Current Advisors List
Founder
More informations about "Allena Pharmaceuticals Boston"
Main Page - Alenapharma
As a member of the Televida Groupโan organization dedicated to advancing Healthtech and Mobile TechโAlena Pharma is uniquely positioned to drive progress in diabetes and โฆSee details»
Allena Pharmaceuticals, Inc. - LinkedIn
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney ...See details»
Allena Pharmaceuticals 2025 Company Profile: โฆ
Information on valuation, funding, cap tables, investors, and executives for Allena Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Allena Pharmaceuticals, Inc. - AnnualReports.com
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney โฆSee details»
Allena Pharmaceuticals - VentureRadar
"Allena Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan โฆSee details»
Allena Pharmaceuticals, Inc. Company Profile | Sudbury, MA ...
Find company research, competitor information, contact details & financial data for Allena Pharmaceuticals, Inc. of Sudbury, MA. Get the latest business insights from Dun & Bradstreet.See details»
Allena Pharmaceuticals - The Org
Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic โฆSee details»
Allena Pharmaceuticals Inc (ALNAQ) Profile - The Globe and Mail
See the company profile for Allena Pharmaceuticals Inc (ALNAQ) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Allena Pharmaceuticals CEO and Key Executive Team | Craft.co
Allena Pharmaceuticals's Vice President of Technical Operations is Hugh Wight. Other executives include Louis Brenner, President and Chief Executive Office; Edward Wholihan, CFO and 3 โฆSee details»
Allena - Company Profile - Tracxn
Jan 31, 2025 Allena is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrology and urologic โฆSee details»
Allena Pharmaceuticals - Craft
Nov 8, 2022 Allena Pharmaceuticals is a company that develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases. It is focused on treating โฆSee details»
Allena Pharmaceuticals Boston - Crunchbase Company Profile
Allena Pharmaceuticals is a biotechnology company that focuses on the development and commercialization of non-systemic protein therapeutics. The company's main objective is to โฆSee details»
Allena Pharmaceuticals' CEO and Executive Team - The Org
Allena Pharmaceuticals' CEO and Executive Team includes Louis Brenner and 5 others.See details»
Allena Pharmaceuticals Company Profile | Management and
Find contact information for Allena Pharmaceuticals. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Allena Pharmaceuticals's email format.See details»
Allena Pharmaceuticals - Bessemer Venture Partners
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 12, 2022 View Allena Pharmaceuticals (www.allenapharma.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โฆSee details»
Allena Pharmaceuticals - Products, Competitors, Financials, โฆ
Nov 2, 2017 About Allena Pharmaceuticals Allena Pharmaceuticals (OTCMKTS: ALNAQ) operates as a pharmaceutical company. It develops oral enzyme therapeutic for the treatment โฆSee details»
Allena Pharmaceuticals Provides Clinical and Corporate
Jan 4, 2022 Allena Pharmaceuticals Provides Clinical and Corporate Update January 04, 2022 05:00 ET | Source: Allena Pharmaceuticals, Inc.See details»
Allena Pharmaceuticals, Inc. (Allena Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก โฆ
The purpose of this Phase IIa study is to evaluate the safety, tolerability and pharmacodynamics of ALLN-346 in subjects with hyperuricemia and gout, and with mild to moderate chronic โฆSee details»
Allena Pharmaceuticals Announces $28 Million Registered
Jul 14, 2021 Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules July 13, 2021 23:43 ET | Source: Allena Pharmaceuticals, โฆSee details»